While further studies need to be performed, it could be likely that the MSC-induced attenuation of HMGB1 contributed to the reduced incidence of ARDS in this treatment group and that HMGB1 is a practical target for treatment or prevention of ARDS as demonstrated in this and previous studies (48, 93). Here, HMGB1 is linked to acute respiratory distress syndrome.